Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

  • Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer

    • Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …

    • Year: 2018

    • Citations: 353

  • Title: Head and neck cancer treatment and physical plasma

    • Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …

    • Year: 2015

    • Citations: 256

  • Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment

    • Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …

    • Year: 2020

    • Citations: 216

  • Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application

    • Authors: HR Metelmann, T Von Woedtke, KD Weltmann

    • Year: 2018

    • Citations: 162

  • Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer

    • Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …

    • Year: 2016

    • Citations: 152

  • Title: Cold atmospheric pressure plasma in wound healing and cancer treatment

    • Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …

    • Year: 2020

    • Citations: 100

  • Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine

    • Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …

    • Year: 2018

    • Citations: 65

  • Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing

    • Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …

    • Year: 2017

    • Citations: 58

  • Title: Ankle laxity: stress investigation under MRI control

    • Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber

    • Year: 2013

    • Citations: 55

  • Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation

    • Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …

    • Year: 2018

    • Citations: 48

  • Title: Physical plasma and leukocytes–immune or reactive?

    • Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt

    • Year: 2018

    • Citations: 42

  • Title: Plasmamedizin

    • Authors: HR Metelmann, T von Woedtke, KD Weltmann

    • Year: 2016

    • Citations: 42

  • Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study

    • Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …

    • Year: 2019

    • Citations: 41

  • Title: Third molars and periodontal damage of second molars in the general population

    • Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …

    • Year: 2018

    • Citations: 36

  • Title: Plasma-derived reactive species shape a differentiation profile in human monocytes

    • Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus

    • Year: 2019

    • Citations: 34

Dr. Babita Rahar | Biochemistry | Best Researcher Award | 3701

Dr. Babita Rahar | Biochemistry | Best Researcher Award 

Postdoc at University of Wisconsin, United States

Dr. Babita Rahar is a dedicated biomedical researcher currently serving as a Postdoctoral Research Associate in Pulmonary Biology at the University of Wisconsin–Madison. With a Ph.D. in Life Sciences from Bharathiar University, her research spans molecular mechanisms of pulmonary fibrosis, fibroblast activation, and extracellular matrix remodeling. She has extensive international research experience across India, South Korea, and the United States. Dr. Rahar has contributed to high-impact publications in Science Advances and Respiratory Research, and she has been recognized with multiple awards, including Best Poster Awards and a Postdoctoral Mentorship Award at UW–Madison. Her technical expertise includes in vivo models, primary cell cultures, histopathology, and advanced imaging techniques. She is deeply committed to translational science, aiming to bridge basic research and clinical applications. With a strong record of collaboration, leadership in project design, and a focus on impactful lung disease research, Dr. Rahar exemplifies the qualities of a rising leader in biomedical research.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Babita Rahar holds a Ph.D. in Life Sciences from Bharathiar University, India, where she investigated the pharmacological efficacy of Sphingosine-1-phosphate under high-altitude hypoxia. She earned her M.S. in Biotechnology from Jawaharlal Nehru University, one of India’s most prestigious institutions, through a highly competitive national entrance exam under the Department of Biotechnology. Her undergraduate studies in Zoology, Botany, and Chemistry were completed at the University of Rajasthan, Jaipur. Throughout her academic journey, Dr. Rahar consistently demonstrated academic excellence, securing major national fellowships including the UGC Junior and Senior Research Fellowships and qualifying multiple national competitive exams such as CSIR-NET, GATE, JAM, and the JNU-DBT entrance test. Her educational background reflects a strong foundation in both theoretical and applied biological sciences, with a clear trajectory toward translational biomedical research. This comprehensive and competitive education prepared her for a successful research career at the intersection of molecular biology, disease modeling, and therapeutic discovery.

Professional Experience

Dr. Babita Rahar’s professional career encompasses over six years of progressive research experience across top institutions in India, South Korea, and the United States. Currently, she is a Postdoctoral Research Associate at the University of Wisconsin–Madison, where she investigates fibroblast activation and extracellular matrix remodeling in pulmonary fibrosis using transgenic mouse models and advanced molecular techniques. Previously, she served as a Postdoctoral Researcher at Ajou University in South Korea, focusing on immune response and peptide therapeutics in inflammatory disease models. In India, she worked as a Project Scientist at ICMR-NIIRNCD, contributing to breast cancer early detection programs and public health interventions. Her roles have involved independent research, collaborative project coordination, mentoring field staff, and grant development. Dr. Rahar’s multi-institutional and multidisciplinary experience demonstrates her adaptability, leadership, and strong problem-solving skills, positioning her as a capable and experienced researcher in both academic and applied biomedical science settings.

Research Interest

Dr. Babita Rahar’s research interests lie at the intersection of molecular medicine, pulmonary biology, and translational therapeutics. Her work primarily focuses on understanding the molecular pathways involved in fibroblast activation and extracellular matrix remodeling, particularly in the context of pulmonary fibrosis. She is skilled in utilizing genetically modified mouse models, primary cell culture, 3D organoids, and precision-cut lung slices (PCLS) to explore disease mechanisms. Dr. Rahar also has strong interests in inflammation biology, hypoxia responses, and biomarker discovery, as demonstrated in her previous research on high-altitude hypoxia and peptide-based immune regulation. She aims to translate basic science discoveries into targeted therapies that improve diagnostic accuracy and therapeutic outcomes. Her long-term vision is to bridge the gap between lab research and clinical application, making significant contributions to personalized medicine, especially in chronic respiratory and inflammatory disorders. Her interdisciplinary focus equips her to tackle complex biomedical questions with clinical relevance.

Award and Honor

Dr. Babita Rahar has received numerous academic and research recognitions that highlight her commitment to scientific excellence. In 2025 and 2024, she earned multiple Best Poster Awards at prestigious research events hosted by the University of Wisconsin–Madison, along with a Postdoctoral Mentorship Award and a Travel Award from the Department of Medicine. Earlier, she was awarded the Senior and Junior Research Fellowships by the University Grants Commission (UGC) of India—highly competitive honors that supported her doctoral studies. Dr. Rahar also successfully qualified elite national-level examinations including CSIR-NET, GATE, JAM, and the JNU-DBT exam, all of which are considered benchmarks of academic distinction in India. Her academic achievements began early, earning the Gargi Award for academic excellence during her school years. These accolades reflect not only her scientific competence but also her consistency, leadership potential, and impactful contributions across multiple stages of her academic and professional career.

Conclusion

Dr. Babita Rahar is a dynamic and accomplished biomedical researcher with a strong foundation in molecular biology and translational medicine. Her educational and professional journey reflects exceptional dedication to advancing research in pulmonary diseases and immune modulation. With a robust publication record, advanced technical expertise, and cross-continental research experience, she stands out as a well-rounded scientist committed to bridging basic science and clinical application. Her work is both impactful and collaborative, contributing significantly to the understanding of complex disease mechanisms such as fibrosis and inflammation. Recognized with multiple awards and fellowships, Dr. Rahar embodies the values of innovation, leadership, and scientific rigor. She is well-positioned to make substantial future contributions to biomedical research and is a highly suitable candidate for recognition through awards such as the Best Researcher Award. Her ongoing efforts are likely to lead to novel therapeutic strategies and improved patient outcomes in critical areas of healthcare.

Publications Top Notes

  • Title: S1P prophylaxis mitigates acute hypobaric hypoxia‐induced molecular, biochemical, and metabolic disturbances: A preclinical report

    • Authors: S. Chawla, B. Rahar, S. Saxena

    • Year: 2016

    • Citations: 20

  • Title: Preventive preclinical efficacy of intravenously administered sphingosine-1-phosphate (S1P) in strengthening hypoxia adaptive responses to acute and sub-chronic hypobaric hypoxia

    • Authors: S. Chawla, B. Rahar, R. Tulswani, S. Saxena

    • Year: 2020

    • Citations: 17

  • Title: Exogenous sphingosine-1-phosphate boosts acclimatization in rats exposed to acute hypobaric hypoxia: assessment of haematological and metabolic effects

    • Authors: S. Chawla, B. Rahar, M. Singh, A. Bansal, D. Saraswat, S. Saxena

    • Year: 2014

    • Citations: 17

  • Title: Sphingosine-1-phosphate pretreatment amends hypoxia-induced metabolic dysfunction and impairment of myogenic potential in differentiating C2C12 myoblasts by stimulating …

    • Authors: B. Rahar, S. Chawla, S. Pandey, A.N. Bhatt, S. Saxena

    • Year: 2018

    • Citations: 13

  • Title: [64Cu]Cu-PEG-FUD peptide for noninvasive and sensitive detection of murine pulmonary fibrosis

    • Authors: H.J. Lee, K. Bernau, T.J. Harr, Z.T. Rosenkrans, G.A. Kessler, K. Stott, A.T. Oler, B. Rahar, et al.

    • Year: 2024

    • Citations: 7

  • Title: Characterization of immune responses associated with ERAP-1 expression in HSV-induced Behçet’s disease mouse model

    • Authors: H.M. Ryu, S.M.S. Islam, H.M. Sayeed, B. Rahar, J.K. Seong, H. Lee, S. Sohn

    • Year: 2023

    • Citations: 7

  • Title: Acute hypobaric hypoxia-mediated biochemical/metabolic shuffling and differential modulation of S1PR-SphK in cardiac and skeletal muscles

    • Authors: B. Rahar, S. Chawla, R. Tulswani, S. Saxena

    • Year: 2019

    • Citations: 5

  • Title: The fibronectin-targeting PEG-FUD imaging probe shows enhanced uptake during fibrogenesis in experimental lung fibrosis

    • Authors: T.J. Harr, N. Gupta, B. Rahar, K. Stott, Y. Medina-Guevara, M.K. Gari, A.T. Oler, et al.

    • Year: 2025

    • Citations: 1

  • Title: PEG-FUD, A Promising Probe for Pulmonary Fibrosis, Targets the Pro-fibrotic Phase of Disease

    • Authors: K. Bernau, T.J. Harr, N. Gupta, K. Stott, B. Rahar, A.T. Oler, Y. Medina-Guevara, et al.

    • Year: 2024

    • Citations: 1

Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

lecturer at Tiangong university, China

Dr. Yunlong Liu is a distinguished structural biologist specializing in transcriptional regulation and nuclear receptor mechanisms. He is currently a Lecturer at Tiangong University, where he contributes to cutting-edge research in biochemistry and molecular biology. His expertise lies in protein structure determination, molecular interactions, and drug discovery, particularly in identifying potent inhibitors for nuclear receptors. With multiple high-impact publications, including Nucleic Acids Research and Cell Discovery, Dr. Liu has established himself as a promising researcher in his field. He has secured national-level research funding and actively contributes to prestigious scientific projects. Recognized for his academic excellence, he has received numerous awards, including the Outstanding Doctoral Dissertation Award and National Ph.D. Scholarship. His work not only advances fundamental biological understanding but also holds potential for therapeutic applications. With a strong foundation in research and teaching, Dr. Liu continues to make significant contributions to the field of structural biology.

Professional Profile

Education

Dr. Yunlong Liu completed his Ph.D. in Biochemistry and Molecular Biology at China Agricultural University in 2023, where he conducted groundbreaking research on structural biology and transcriptional regulation. His doctoral work involved the determination of multiple protein and nucleic acid complex structures, providing critical insights into nuclear receptor function. During his Ph.D., he was recognized for his exceptional academic performance, receiving the Outstanding Doctoral Dissertation Award and National Ph.D. Scholarship. Prior to his doctoral studies, he earned his undergraduate degree from a prestigious institution, excelling in both coursework and research. His academic journey has been marked by a strong emphasis on molecular mechanisms and protein interactions, laying the foundation for his current research. With a solid background in structural biology and biochemistry, Dr. Liu has developed expertise in crystallography, molecular modeling, and drug discovery, positioning him as a leading researcher in his field.

Professional Experience

Dr. Yunlong Liu is currently a Lecturer in the College of Life Sciences at Tiangong University, where he teaches and mentors students in biochemistry and molecular biology. Before this role, he conducted extensive doctoral research at China Agricultural University, focusing on protein structural analysis and transcriptional regulation. His research contributions include the identification of a highly potent nuclear receptor inhibitor and the resolution of multiple protein-DNA complex structures. As a key member of several national research projects, he has played an instrumental role in advancing molecular biology research in China. He has also secured independent research funding, serving as the Principal Investigator for a National Natural Science Foundation of China project. His professional experience extends beyond academia, as his research findings have implications for pharmaceutical development and biomedical sciences. Through his teaching and research, Dr. Liu continues to shape the next generation of scientists while making significant contributions to his field.

Research Interests

Dr. Yunlong Liu’s research focuses on the molecular mechanisms of transcriptional regulation, nuclear receptor functions, and protein-nucleic acid interactions. His work in structural biology involves determining the 3D structures of key biomolecules using advanced crystallography techniques, providing crucial insights into gene regulation and disease pathways. He is particularly interested in studying nuclear receptors and their role in gene expression, with the aim of identifying novel therapeutic targets for metabolic and genetic disorders. His research has led to the discovery of a nuclear receptor inhibitor with significantly enhanced efficacy, highlighting the potential for drug development. Additionally, he explores epigenetic modifications and their structural basis, contributing to the broader understanding of gene regulation. With a strong commitment to advancing biomedical research, Dr. Liu continues to explore new methodologies and collaborative approaches to address fundamental questions in biochemistry and molecular biology.

Awards and Honors

Dr. Yunlong Liu has been widely recognized for his outstanding contributions to structural biology and molecular research. He received the Outstanding Doctoral Dissertation Award from China Agricultural University, an honor granted to only one recipient in his college. His academic excellence also earned him the National Ph.D. Scholarship, where he ranked second in his college. Throughout his career, he has been involved in prestigious research projects funded by national and provincial organizations, including the National Natural Science Foundation of China and the Tianjin Top Scientist Studio Program. His achievements in protein structure determination and transcriptional regulation have led to publications in top-tier journals such as Nucleic Acids Research and Cell Discovery. His early accomplishments include awards in mathematical modeling competitions and national scholarships during his undergraduate studies. With a track record of excellence, Dr. Liu continues to receive accolades for his impactful research and academic contributions.

Conclusion

Dr. Yunlong Liu is a strong candidate for the Best Researcher Award, given his high-impact research, prestigious awards, and leadership in structural biology. His work in transcriptional regulation and nuclear receptors is scientifically significant and widely recognized. Strengthening international collaborations, expanding independent funding, and showcasing mentorship contributions could further elevate his standing.

Publications Top Noted

1. Nucleic Acid-Based Therapies

  • Title: The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
  • Authors: Liu, Y., Wang, C., Fu, X., & Ren, M.
  • Year: 2025
  • Journal: Biomolecules
  • DOI: 10.3390/biom15030376

2. Nucleic Acid Recognition and 6mA Demethylation

  • Title: Structural Basis of Nucleic Acid Recognition and 6mA Demethylation by Caenorhabditis elegans NMAD-1A
  • Authors: Shang, G., Yang, M., Li, M., Ma, L., Liu, Y., Ma, J., Chen, Y., Wang, X., Fan, S., Xie, M., et al.
  • Year: 2024
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms25020686

3. Transcriptional Regulation and Structural Insights

  • Title: Structures of Human TR4LBD–JAZF1 and TR4DBD–DNA Complexes Reveal the Molecular Basis of Transcriptional Regulation
  • Authors: Liu, Y., Ma, L., Li, M., Tian, Z., Yang, M., Wu, X., Wang, X., Shang, G., Xie, M., Chen, Y., et al.
  • Year: 2023
  • Journal: Nucleic Acids Research
  • DOI: 10.1093/nar/gkac1259

4. Molecular Recognition of Nucleosomes

  • Title: Structures of MPND Reveal the Molecular Recognition of Nucleosomes
  • Authors: Yang, M., Li, X., Tian, Z., Ma, L., Ma, J., Liu, Y., Shang, G., Liang, A., Wu, W., Chen, Z.
  • Year: 2023
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms24043368

5. Epigenetic Functions and Nucleic Acid Repair

  • Title: Structural Insights into the Interactions and Epigenetic Functions of Human Nucleic Acid Repair Protein ALKBH6
  • Authors: Ma, L., Lu, H., Tian, Z., Yang, M., Ma, J., Shang, G., Liu, Y., Xie, M., Wang, G., Wu, W., et al.
  • Year: 2022
  • Journal: Journal of Biological Chemistry
  • DOI: 10.1016/j.jbc.2022.101671

6. Protein-DNA Complex and Recognition Mechanisms

  • Title: Crystal Structures of REF6 and Its Complex with DNA Reveal Diverse Recognition Mechanisms
  • Authors: Tian, Z., Li, X., Li, M., Wu, W., Zhang, M., Tang, C., Li, Z., Liu, Y., Chen, Z., Yang, M., et al.
  • Year: 2020
  • Journal: Cell Discovery
  • DOI: 10.1038/s41421-020-0150-6